A detailed history of Sgl Investment Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Sgl Investment Advisors, Inc. holds 3,201 shares of AMGN stock, worth $1.09 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
3,201
Previous 2,100 52.43%
Holding current value
$1.09 Million
Previous $624 Million 52.07%
% of portfolio
0.4%
Previous 0.3%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$271.18 - $309.22 $298,569 - $340,451
1,101 Added 52.43%
3,201 $948 Million
Q2 2025

Jul 23, 2025

BUY
$262.28 - $309.85 $7,606 - $8,985
29 Added 1.4%
2,100 $624 Million
Q1 2025

May 09, 2025

SELL
$258.59 - $327.36 $16,032 - $20,296
-62 Reduced 2.91%
2,071 $563 Million
Q4 2024

Feb 13, 2025

SELL
$258.78 - $328.31 $138,447 - $175,645
-535 Reduced 20.05%
2,133 $629 Million
Q3 2024

Nov 15, 2024

BUY
$309.38 - $337.38 $825,425 - $900,129
2,668 New
2,668 $790 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sgl Investment Advisors, Inc. Portfolio

Follow Sgl Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sgl Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sgl Investment Advisors, Inc. with notifications on news.